Pere Santamaria
Grup de recerca
- Patogènia i tractament de l'autoimmunitat Group leader (R4)
 
Publicacions destacades
- 
                    
Quantifying immunoregulation by autoantigen-specific T-regulatory type 1 cells in mice with simultaneous hepatic and extra-hepatic autoimmune disorders
Autors:Referència: Immunology 2020. - 
                    
Ubiquitous antigen-specific T regulatory type 1 cells variably suppress hepatic and extrahepatic autoimmunity
Autors:Referència: Journal Of Clinical Investigation 2020. - 
                    
Increased yields and biological potency of knob-into-hole-based soluble MHC class II molecules
Autors:Referència: Nature Communications 2019. - 
                    
Suppression of a broad spectrum of liver autoimmune pathologies by single peptide-MHC-based nanomedicines
Autors:Referència: Nature Communications 2019. - 
                    
Antigen-specific therapeutic approaches for autoimmunity
Autors:Referència: Nature Biotechnology 2019. - 
                    
Taming autoimmunity: Translating antigen-specific approaches to induce immune tolerance
Autors:Referència: Journal Of Experimental Medicine 2019. - 
                    
In vivo clearance of nanoparticles by transcytosis across alveolar epithelial cells
Autors:Referència: Plos One 2019. - 
                    
Nanoparticles for Immune Stimulation Against Infection, Cancer, and Autoimmunity
Autors:Referència: Acs Nano 2018. - 
                    
Nanoparticle-based approaches to immune tolerance for the treatment of autoimmune diseases.
Autors:Referència: European Journal Of Immunology 2018. - 
                    
A Gut Microbial Mimic that Hijacks Diabetogenic Autoreactivity to Suppress Colitis
Autors:Referència: Cell 2017. 
